BeStock  

United Therapeutics UTHR

US equityMarket cap rank #819Drug Manufacturers - Specialty & Generic
$554.73 −$4.37 (-0.78%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $550.23 -0.81%
Open$561.20
Prev close$559.10
Day range$551.77 – $563.12
Volume531.8K
Market cap$23.63B
P/E (TTM)20.9
Dividend yield–

Valuation

Multiples measured against the stock's own five-year history

Price / earnings20.9x
CheapRich

Near the top of its 5-year range · 96th percentile, 5-year average 16.0x

#1767 of 2996 stocks by PE (1 = cheapest)

Price / book3.8x
CheapRich

Near the top of its 5-year range · 93rd percentile, 5-year average 2.5x

#4172 of 5338 stocks by PB (1 = cheapest)

Price / sales7.4x
CheapRich

Near the top of its 5-year range · 94th percentile, 5-year average 5.8x

#4373 of 5161 stocks by PS (1 = cheapest)

P/E over five years

10x15x19x23xOct '21Apr '24Nov '26

Dashed line is the 5-year average; the shaded band is one standard deviation either side.

Morningstar fair value estimate

Fair value$571.69
Price vs. fair value-3.0%Close to the estimate
Star rating★★★☆☆
Economic moatNarrow
UncertaintyMedium
MultipleCurrentForward5y averagePercentile vs. own historyIndustry rank
PB 3.76 – 2.54 93% (pricier than usual) #4172 of 5338 (1 = cheapest)
PE 20.94 22.54 16.02 96% (pricier than usual) #1767 of 2996 (1 = cheapest)
PS 7.41 7.05 5.76 94% (pricier than usual) #4373 of 5161 (1 = cheapest)

Percentile is against this stock’s own 5-year valuation range: higher means it’s trading rich relative to its own history, lower means cheap relative to its own history — it is not a comparison against other companies. Forward multiples use consensus estimates for the next twelve months; a forward multiple below the current one usually signals analysts expect earnings to grow.

Discussion

No comments yet — be the first to weigh in on UTHR.

Sign in to join the discussion.

Scroll to Top